ArticleLeukemia & lymphoma2022

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

Konstantinos Lontos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.